You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gazyva

Showing 1 - 25 of 96
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Follicular Lymphoma, Tumor Trial in Houston (Obinutuzumab, CC-99282)

Not yet recruiting
  • Follicular Lymphoma
  • Tumor
  • Houston, Texas
    M D Anderson Cancer Center
Oct 30, 2023

Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])

Not yet recruiting
  • Immune Thrombocytopenia
  • Treatment
  • Obinutuzumab Injection [Gazyva]
  • Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Aug 9, 2023

DLBCL Trial in Suzhou (Chidamide, Azacitidine, obinutuzumab)

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Apr 10, 2023

Urothelial Carcinoma Trial in New York (Naptumomab Estafenatox, Pembrolizumab, Obinutuzumab)

Not yet recruiting
  • Urothelial Carcinoma
  • Naptumomab Estafenatox
  • +2 more
  • New York, New York
    Weill Cornell Medicine/NewYork-Presbyterian Hospital
May 30, 2023

Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])

Not yet recruiting
  • Immune Thrombocytopenia
  • Treatment
  • Obinutuzumab Injection [Gazyva]
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital, Chinese Aca
Oct 17, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Rituximab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Dec 5, 2022

Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Non-hodgkin Lymphoma Trial in Boston (Obinutuzumab, Glofitamab)

Not yet recruiting
  • Follicular Lymphoma
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Mar 13, 2023

Chronic Lymphocytic Leukemia, Richter's Transformation Trial in Boston (Glofitamab, Obinutuzumab, Polatuzumab Vedotin)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Richter's Transformation
  • Boston, Massachusetts
  • +1 more
Sep 12, 2023

Leukemia, Lymphocytic, Chronic, B-Cell Trial in New York (Zanubrutinib Pill, Venetoclax Pill, Obinutuzumab Injection)

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Zanubrutinib Pill
  • +2 more
  • New York, New York
    Weill Cornell Medicine/NewYork-Presberteryian Hospital
Dec 6, 2022

Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Trial in Suzhou (Obinutuzumab, Zanubrutinib, Lenalidomide)

Enrolling by invitation
  • Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Mar 22, 2023

Obinutuzumab in Follicular Lymphoma or Previously Untreated

Recruiting
  • Chronic Lymphocytic Leukemia
  • Follicular Lymphoma
  • obinutuzumab
  • Busan, Korea, Republic of
  • +16 more
Jul 1, 2022

Gazyva Infusion Reaction Investigation

Recruiting
  • Chronic Lymphocytic Leukemia
    • Moscow, Russian Federation
    • +1 more
    Feb 11, 2022

    Mantle Cell Lymphoma, Refractory Lymphoma Trial in Boston (Acalabrutinib, Venetoclax, Obinutuzumab)

    Recruiting
    • Mantle Cell Lymphoma
    • Refractory Lymphoma
    • Boston, Massachusetts
    • +1 more
    Aug 8, 2022

    CCND1 Positive, Mantle Cell Lymphoma, t(11;14) Positive Trial in Atlanta, Johns Creek (Bendamustine, Obinutuzumab, Venetoclax)

    Active, not recruiting
    • CCND1 Positive
    • +2 more
    • Atlanta, Georgia
    • +2 more
    Nov 2, 2022

    Leukemia Trial in Houston (Pirtobrutinib, Obinutuzumab, Venetoclax)

    Not yet recruiting
    • Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 7, 2022

    Chronic Lymphocytic Leukemia (CLL) Trial in United States (Venetoclax, Obinutuzumab, Acalabrutinib)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • Stamford, Connecticut
    • +4 more
    Dec 2, 2022

    Follicular Lymphoma Trial in Chicago (Venetoclax, Obinutuzumab, CC-486)

    Recruiting
    • Follicular Lymphoma
    • Chicago, Illinois
      University of Chicago Medical Center
    Nov 12, 2021

    Leukemia, Lymphocytic, Chronic Trial run by the NCI (rhIL-15, Obinutuzumab)

    Terminated
    Has Results
    • Leukemia
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Mar 11, 2022

    Follicular Lymphoma Trial in Australia (Obinutuzumab 25 MG/1 ML Intravenous Solution, Atezolizumab 1200 MG/40mL Intravenous

    Recruiting
    • Follicular Lymphoma
    • Obinutuzumab 25 MG/1 ML Intravenous Solution
    • +2 more
    • Ballarat, Victoria, Australia
    • +3 more
    Jul 28, 2022

    Large B-cell Lymphoma Trial in Philadelphia (mosunetuzumab, glofitamab, obinutuzumab)

    Recruiting
    • Large B-cell Lymphoma
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Jul 21, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (Acalabrutinib, Obinutuzumab, Venetoclax)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Nov 2, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Acalabrutinib, Obinutuzumab)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 14, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia Trial in Columbus (acalabrutinib,

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +2 more
    • Columbus, Ohio
      Research Site
    Mar 11, 2022

    Grade 3a Follicular Lymphoma, Recurrent Follicular Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Houston (other,

    Completed
    • Grade 3a Follicular Lymphoma
    • +9 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 31, 2023

    Chronic Lymphocytic Leukemia Trial in Portland (drug, procedure, biological, other)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jul 12, 2023